Skip to main content
. 2015 May 26;84(21):2185–2192. doi: 10.1212/WNL.0000000000001608

Table 1.

Initial (market release date) and current annual costs (December 2013) of multiple sclerosis disease-modifying therapies in the United States relative to consumer price index changes during the same period

graphic file with name NEUROLOGY2014614974TT1.jpg